-+ 0.00%
-+ 0.00%
-+ 0.00%

Palisade Bio says PALI-2108 Phase 1 ulcerative colitis data set for DDW poster

PUBT·04/16/2026 15:44:53
Listen to the news
Palisade Bio says PALI-2108 Phase 1 ulcerative colitis data set for DDW poster
  • Palisade Bio disclosed that Phase 1 translational findings for lead ulcerative colitis program PALI-2108 were selected for poster presentation at Digestive Disease Week 2026.
  • Results will be presented May 5, 2026, with no prior presentation referenced.
  • Data showed rapid improvement across clinical symptoms, tissue-level inflammation, and biomarkers, supporting gut-targeted PDE4 inhibition as a potential once-daily oral approach.
  • Management plans one-on-one meetings with qualified investors during DDW 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604160850PRIMZONEFULLFEED9690874) on April 16, 2026, and is solely responsible for the information contained therein.